Robert G. Stern

1.4k total citations
25 papers, 1.1k citations indexed

About

Robert G. Stern is a scholar working on Psychiatry and Mental health, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Robert G. Stern has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Robert G. Stern's work include Schizophrenia research and treatment (9 papers), Congenital Diaphragmatic Hernia Studies (4 papers) and Neonatal Respiratory Health Research (4 papers). Robert G. Stern is often cited by papers focused on Schizophrenia research and treatment (9 papers), Congenital Diaphragmatic Hernia Studies (4 papers) and Neonatal Respiratory Health Research (4 papers). Robert G. Stern collaborates with scholars based in United States, Australia and Israel. Robert G. Stern's co-authors include Linda M. Bierer, Richard C. Mohs, James Schmeidler, Jeremy M. Silverman, Keith L. Davis, Michael H. Davidson, Elisse Kramer‐Ginsberg, Robert J. Herfkens, Christopher E. Cann and Bruce H. Brundage and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and The American Journal of Medicine.

In The Last Decade

Robert G. Stern

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert G. Stern United States 18 518 280 219 169 108 25 1.1k
Göran Långström Sweden 17 168 0.3× 172 0.6× 224 1.0× 264 1.6× 160 1.5× 34 1.6k
H. G. Gemmell United Kingdom 19 358 0.7× 214 0.8× 209 1.0× 83 0.5× 114 1.1× 50 1.3k
Kari Alhainen Finland 13 620 1.2× 126 0.5× 553 2.5× 122 0.7× 296 2.7× 20 1.6k
Gunhild Waldemar Denmark 17 442 0.9× 170 0.6× 229 1.0× 68 0.4× 78 0.7× 29 1.1k
Rong-Chi Chen Taiwan 19 294 0.6× 171 0.6× 183 0.8× 48 0.3× 168 1.6× 38 1.2k
Takefumi Yuzuriha Japan 19 216 0.4× 155 0.6× 205 0.9× 31 0.2× 132 1.2× 55 1.0k
Ólafur Aevarsson Sweden 13 632 1.2× 79 0.3× 427 1.9× 46 0.3× 160 1.5× 17 1.2k
Harald Ihmsen Germany 24 240 0.5× 191 0.7× 356 1.6× 304 1.8× 297 2.8× 90 2.4k
Billy Dunn United States 11 454 0.9× 113 0.4× 493 2.3× 87 0.5× 29 0.3× 22 1.4k
Holly Posner United States 14 557 1.1× 95 0.3× 249 1.1× 54 0.3× 103 1.0× 22 984

Countries citing papers authored by Robert G. Stern

Since Specialization
Citations

This map shows the geographic impact of Robert G. Stern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert G. Stern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert G. Stern more than expected).

Fields of papers citing papers by Robert G. Stern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert G. Stern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert G. Stern. The network helps show where Robert G. Stern may publish in the future.

Co-authorship network of co-authors of Robert G. Stern

This figure shows the co-authorship network connecting the top 25 collaborators of Robert G. Stern. A scholar is included among the top collaborators of Robert G. Stern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert G. Stern. Robert G. Stern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aiyer, Rohit, et al.. (2016). Valproic Acid Induced Hyperammonemia in a Long Time Treated Patient. Case Reports in Psychiatry. 2016. 1–4. 11 indexed citations
2.
Stern, Robert G.. (2012). The Incidental Solitary Pulmonary Nodule: Algorithms, Options, and Patient Choice. The American Journal of Medicine. 125(3). 221–222. 1 indexed citations
3.
Stern, Robert G., et al.. (2009). Aripiprazole for the Treatment of Schizophrenia With Co-Occurring Social Anxiety. Journal of Clinical Psychopharmacology. 29(3). 206–209. 17 indexed citations
4.
Stern, Robert G., Barton N. Milestone, & Robert A. Gatenby. (1999). Carcinogenesis and the plasma membrane. Medical Hypotheses. 52(5). 367–372. 31 indexed citations
5.
Howanitz, Evelyn, et al.. (1999). The Efficacy and Safety of Clozapine Versus Chlorpromazine in Geriatric Schizophrenia. The Journal of Clinical Psychiatry. 60(1). 41–44. 62 indexed citations
6.
Milestone, Barton N., Thomas F. Miller, M. R. Wolfson, Robert G. Stern, & Thomas H. Shaffer. (1997). Virtual bronchoscopy with perfluoronated hydrocarbon enhancement. Academic Radiology. 4(8). 583–586. 8 indexed citations
7.
Stern, Robert G., James Schmeidler, & Michael Davidson. (1997). Limitations of controlled augmentation trials in schizophrenia. Biological Psychiatry. 42(2). 138–143. 21 indexed citations
8.
Shaffer, Thomas H., Marla R. Wolfson, J. S. Greenspan, S. David Rubenstein, & Robert G. Stern. (1994). Perfluorochemical Liquid as a Respiratory Medium. Artificial Cells Blood Substitutes and Biotechnology. 22(2). 315–326. 26 indexed citations
9.
Wolfson, Marla R., et al.. (1994). Utility of a Perfluorochemical Liquid for Pulmonary Diagnostic Imaging. Artificial Cells Blood Substitutes and Biotechnology. 22(4). 1409–1420. 30 indexed citations
10.
Stern, Robert G., et al.. (1993). High-Resolution Computed Tomographic Bronchiolography Using Perfluoroctylbromide (PFOB). Journal of Thoracic Imaging. 8(4). 300–304. 18 indexed citations
11.
Stern, Robert G., et al.. (1993). Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia. Psychiatry Research. 46(2). 151–163. 39 indexed citations
12.
Bierer, Linda M., Paul Aisen, Michael Davidson, et al.. (1993). A Pilot Study of Oral Physostigmine Plus Yohimbine in Patients with Alzheimer Disease. Alzheimer Disease & Associated Disorders. 7(2). 98–104. 14 indexed citations
13.
Stern, Robert G., RenéS. Kahn, Philip D. Harvey, et al.. (1993). Early response to haloperidol treatment in chronic schizophrenia. Schizophrenia Research. 10(2). 165–171. 31 indexed citations
14.
Stern, Robert G., Richard C. Mohs, Linda M. Bierer, et al.. (1992). Deterioration on the blessed test in Alzheimer's disease: Longitudinal data and their implications for clinical trials and identification of subtypes. Psychiatry Research. 42(2). 101–110. 34 indexed citations
15.
Stern, Robert G. & Richard C. Mohs. (1992). The authors reply. Psychiatry Research. 44(2). 168–168. 1 indexed citations
16.
Kahn, René S., et al.. (1992). Nocturnal growth hormone secretion in schizophrenic patients and healthy subjects. Psychiatry Research. 41(2). 155–161. 15 indexed citations
17.
Kahn, RenéS., Larry J. Siever, Farooq Amin, et al.. (1992). Serotonin function in schizophrenia: Effects of meta- chlorophenylpiperazine in schizophrenia patients and healthy subjects. Psychiatry Research. 43(1). 1–12. 40 indexed citations
18.
Davidson, Michael, et al.. (1991). Cholinergic strategies in the treatment of Alzheimer's disease. Acta Psychiatrica Scandinavica. 83(S366). 47–51. 17 indexed citations
19.
Stern, Robert G., et al.. (1991). Diagnostic and Pharmacological Approaches in Alzheimer??s Disease. Drugs & Aging. 1(2). 144–162. 19 indexed citations
20.
Kuriyama, Keiko, G Gamsu, Robert G. Stern, et al.. (1984). CT-Determined Pulmonary Artery Diameters in Predicting Pulmonary Hypertension. Investigative Radiology. 19(1). 16–22. 206 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Göran Långström Breakdown of academic impact, for papers by H. G. Gemmell Breakdown of academic impact, for papers by Kari Alhainen Breakdown of academic impact, for papers by Gunhild Waldemar Breakdown of academic impact, for papers by Rong-Chi Chen Breakdown of academic impact, for papers by Takefumi Yuzuriha Breakdown of academic impact, for papers by Ólafur Aevarsson Breakdown of academic impact, for papers by Harald Ihmsen Breakdown of academic impact, for papers by Billy Dunn Breakdown of academic impact, for papers by Holly Posner
Rankless by CCL
2026